| abstract |
The present invention provides a pharmaceutical composition comprising a substance that suppresses the proliferation of synovial tissue or synovial cells and the production of interleukin-6, and is at least one selected from rheumatism, fibrosis, arthritis, cancer and cranial nerve disease. Useful for diagnosing or treating two diseases, a pharmaceutical composition that suppresses the proliferation of synovial tissue or synovial cells and the production of interleukin-6, and suppresses the expression of hsHRD3 in synovial cells This is a method for suppressing the proliferation of synoviocytes and the production of interleukin-6. |